Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

OU Health Stephenson Cancer, Oklahoma City, Oklahoma

Swedish Center for Research and Innovation, Seattle, Washington